Actinogen Medical Limited
ATGGF
$0.025
$0.0014.17%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | 1.76M | 1.72M | -- | -- | 2.97M |
| Total Revenue | 1.76M | 1.72M | -- | -- | 2.97M |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 1.76M | 1.72M | -- | -- | 2.97M |
| SG&A Expenses | 1.46M | 1.43M | 1.17M | 1.20M | 1.26M |
| Depreciation & Amortization | 70.40K | 68.90K | 66.00K | 67.90K | 67.50K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.00M | 3.92M | 2.72M | 2.80M | 3.50M |
| Operating Income | -2.24M | -2.19M | -2.72M | -2.80M | -528.10K |
| Income Before Tax | -2.10M | -2.06M | -2.66M | -2.74M | -490.20K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.10M | -2.06M | -2.66M | -2.74M | -490.20K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.10M | -2.06M | -2.66M | -2.74M | -490.20K |
| EBIT | -2.24M | -2.19M | -2.72M | -2.80M | -528.10K |
| EBITDA | -2.18M | -2.14M | -2.67M | -2.75M | -474.30K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 3.04B | 3.04B | 2.92B | 2.92B | 2.28B |
| Average Diluted Shares Outstanding | 3.04B | 3.04B | 2.92B | 2.92B | 2.28B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |